Biodesix, Inc. reaffirmed revenue guidance for the full year 2024. for the year, the company expects total revenue of $65 million and $68 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.738 USD | +1.05% |
|
+7.28% | -5.54% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.54% | 250M | |
-18.17% | 8.55B | |
+86.28% | 4.63B | |
+16.31% | 2.98B | |
-3.15% | 2.65B | |
-4.79% | 1.89B | |
-53.27% | 1.81B | |
-13.30% | 1.56B | |
+21.59% | 1.27B | |
-47.96% | 1.07B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Reaffirms Revenue Guidance for the Full Year 2024